# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Although U.S. stocks closed mostly lower on Friday, there were a few notable insider trades.
HC Wainwright & Co. analyst Yi Chen reiterates Greenwich LifeSciences (NASDAQ:GLSI) with a Buy and maintains $36 price t...
The Company's application to expand Flamingo-01 into Europe has been formally approved by Spain, France, Germany, Italy, an...
The Company was informed that the manufacturing, non-clinical, clinical, statistical, and regulatory sections of its applicatio...
HC Wainwright & Co. analyst Yi Chen maintains Greenwich LifeSciences (NASDAQ:GLSI) with a Buy and lowers the price targe...
Greenwich Lifesciences shares are trading higher by 30.6% Wednesday afternoon. The company provided an update on the Phase III ...